Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for detecting 9-nitrominocycline in tigecycline for injection

A technology of nitrominocycline and tigecycline, which is applied in the detection field of 9-nitrominocycline in tigecycline for injection, and can solve the problem that 9-nitrominocycline cannot be quantified effectively And other issues

Active Publication Date: 2020-04-24
瀚晖制药有限公司
View PDF7 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] The main purpose of the present invention is to provide a detection method for 9-nitrominocycline in tigecycline for injection, to solve the problem of trace 9-nitrominocycline in tigecycline for injection in the prior art. Cyclocycline can not be effectively quantified problem

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for detecting 9-nitrominocycline in tigecycline for injection
  • Method for detecting 9-nitrominocycline in tigecycline for injection
  • Method for detecting 9-nitrominocycline in tigecycline for injection

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] The process of establishing the standard curve

[0042] The standard solution preparation process is as follows:

[0043] The standard solution is the system suitability solution: use methanol to dilute 14.1 mg of 9-nitrominocycline standard sample (equivalent to 12 mg of 9-nitrominocycline) step by step, and prepare them respectively to a concentration of 0.05 μg / mL , a single standard solution of 0.25 μg / mL carries out the detection process of high performance liquid chromatography tandem mass spectrometry to the standard solution as follows:

[0044] The conditions for HPLC detection are set as follows: the chromatographic column is a Welch XB-C18 chromatographic column, and the chromatographic column size is 4.6×50mm, 5μm, the column temperature is 35°C, the flow rate is 0.5ml / min, and the mobile phase A is volume The formic acid content is 0.1%, the mobile phase B is acetonitrile, and the gradient elution process is: 0 ~ 2min using 75% mobile phase A and 25% mob...

Embodiment 2

[0071] Different from the detection conditions of Example 1, the details are as follows.

[0072] The conditions for HPLC detection are set as follows: the chromatographic column is a Welch XB-C18 chromatographic column, and the chromatographic column size is 4.6×50mm, 5μm, the column temperature is 30°C, the flow rate is 0.3ml / min, and the mobile phase A is volume The formic acid content is 0.2%, the mobile phase B is acetonitrile, and the gradient elution process is: 0 ~ 2min using 70% mobile phase A and 30% mobile phase B for elution, 2 ~ 8min using 1% mobile phase A and 99% mobile phase B was used for elution, and 70% mobile phase A and 30% mobile phase B were used for elution in 8-13 minutes.

[0073] The conditions for mass spectrometry detection are set as follows: the ion source is AJS ESI, the drying gas temperature is 310°C, the drying gas flow rate is 9L / min, the atomizing gas pressure is 30psi, the sheath gas temperature is 330°C, and the sheath flow rate is 10L / mi...

Embodiment 3

[0076] Different from the detection conditions of Example 1, the details are as follows.

[0077] The conditions for HPLC detection are set as follows: the chromatographic column is a Welch XB-C18 chromatographic column, and the chromatographic column size is 4.6×50mm, 5μm, the column temperature is 40°C, the flow rate is 0.8ml / min, and the mobile phase A is volume The content is 0.05% formic acid, mobile phase B is acetonitrile, the gradient elution process is: 0 ~ 2min adopts 80% mobile phase A and 20% mobile phase B to elute, 2 ~ 8min adopts 3% mobile phase A and 97% mobile phase B was used for elution, and 80% mobile phase A and 20% mobile phase B were used for elution in 8-13 minutes.

[0078] The conditions for mass spectrometry detection are set as follows: the ion source is AJS ESI, the drying gas temperature is 280°C, the drying gas flow rate is 7L / min, the atomizing gas pressure is 40psi, the sheath flow gas temperature is 360°C, and the sheath flow flow rate is 12L / ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
recovery rateaaaaaaaaaa
Login to View More

Abstract

The invention provides a method for detecting 9-nitrominocycline in tigecycline for injection. The detection method comprises the following steps: step S1, obtaining a standard curve of high performance liquid chromatography tandem mass spectrometry of 9-nitrominocycline, wherein the vertical coordinate of the standard curve is the characteristic ion peak area of 9-nitrominocycline, and the horizontal coordinate is the mass content of 9-nitrominocycline; step S2, dissolving tigecycline for injection to form a tigecycline solution, and performing high performance liquid chromatography tandem mass spectrometry detection on the tigecycline solution to obtain a mass chromatogram; and step S3, determining the characteristic ion peak of the 9-nitrominocycline in the mass chromatogram according to the analysis result of the mass chromatogram, and calculating the mass content of the 9-nitrominocycline by taking the peak area of the characteristic ion peak as the basis of the standard curve. According to the detection method, the accurate mass content of the 9-nitrominocycline can be obtained and a reliable data basis can be provided for effective mass control of the 9-nitrominocycline.

Description

technical field [0001] The invention relates to the technical field of quality control of tigecycline, in particular to a method for detecting 9-nitrominocycline in tigecycline for injection. Background technique [0002] Tigecycline (Tigecycline), developed by the Wyeth Pharmaceutical Company of the United States, is a new type of broad-spectrum active intravenous antibiotics. It is also active against drug-resistant methicillin-resistant Staphylococcus aureus. It is a glycylcycline class The first drug in , has the following chemical structure: [0003] [0004] According to the synthesis process of tigecycline, known impurities that may exist in tigecycline include epiminocycline, minocycline, 9-aminominocycline, 9-nitrominocycline, N - tert-butylglycine, epimers, oxides, quinone analogs, tricyclics, etc., among which 9-nitrominocycline is a key intermediate for the production of tigecycline, and is a genotoxic Impurities. However, in the prior art, the quantitative...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G01N30/88
CPCG01N30/88G01N2030/027G01N2030/8872
Inventor 徐慧娟杜加秋姜丽丽赵技宇夏莉
Owner 瀚晖制药有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com